A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ABL Bio Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Total Equity
â‚©53.2B
CAGR 3-Years
-22%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Equity
â‚©17T
CAGR 3-Years
65%
CAGR 5-Years
44%
CAGR 10-Years
30%
SK Bioscience Co Ltd
KRX:302440
Total Equity
â‚©1.7T
CAGR 3-Years
86%
CAGR 5-Years
51%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Equity
â‚©817.1B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Equity
â‚©510B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Equity
â‚©177.3B
CAGR 3-Years
1%
CAGR 5-Years
23%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Total Equity?
Total Equity
53.2B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Total Equity amounts to 53.2B KRW.

What is ABL Bio Inc's Total Equity growth rate?
Total Equity CAGR 5Y
-8%

Over the last year, the Total Equity growth was -6%. The average annual Total Equity growth rates for ABL Bio Inc have been -22% over the past three years , -8% over the past five years .

Back to Top